One of many challenges of the miRNA-based therapy depends on the effective and selective delivery of miRNA substances to focus on cells. effective, restorative strategy. The latest identification of the STAT3-mediated miR-146b down-regulation in neutropenic T-LGLL individuals emphasized the pathogenetic part of STAT3 activation in neutropenia advancement. Appropriately, JAK/STAT3 axis Continue Reading